Clorox is trading 4.3% up at $102.45 after investors reacted positively to the company's Q4 FY26 earnings report and optimistic fiscal 2027 outlook.
- Management forecast FY27 net sales growth of 13%–14% and adjusted EPS of $5.70–$6.00, highlighting expected contributions from the $2.25B GOJO (Purell) acquisition.
- The strong guidance helped offset concerns regarding FY26 organic sales, which faced pressure from ERP transition headwinds, while the stock also benefited from a broadly positive U.S. equity market.